BioSpace News Archive

Select Medical Holdings Corporation announced results for its first quarter ended March 31, 2020.

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that it will host a conference call on Thursday, May 7, 2020, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31

Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the first quarter ended March 31, 2020.

COVID-19 is a global public health challenge that continues to evolve rapidly.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Manja Boerman, Ph.D., to the role of President, Cell & Gene Therapy, effective June 1, 2020.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it was granted U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company’s SARS-CoV-2 Total Ab test, the first total antibody test receiving EUA from the FDA.

LeMaitre Vascular, Inc., a provider of vascular devices, implants and services, reported Q1 2020 results and announced a $0.095/share quarterly dividend.

ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020.

Savara Inc., an orphan lung disease company, announced that the Company will report first quarter 2020 financial results and provide a business update on Thursday, May 7, 2020.

Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the three months ended March 31, 2020.